Carrington Laboratories, Inc., of Irving, Texas, has appointedChristopher Record as vice president, finance and administration andchief financial officer.Amylin Pharmaceuticals, Inc., of San Diego, Calif., has appointed JohnMullane to the new position of executive vice president ofdevelopment.Corange, of London, England, has named Jurgen Schrenk vicepresident, technology management, and Tom Kegley vice president,information technology.Sonus Pharmaceuticals, of Costa Mesa, Calif., has appointed RalphSabin chief financial officer.Immunex Corp., of Seattle, has promoted Carrie McAninch to be vicepresident of manufacturing operations.Genta Inc., of San Diego, Calif., has promoted Howard Sampson tovice president and chief financial officer.Microcide Pharmaceuticals Inc., of Mountain View, Calif., has namedJim Rurka president and chief executive officer, and added SydneyBrenner of the Scripps Institute to its scientific advisory board.Sequana Therapeutics, Inc., of La Jolla, Calif., has appointed AudreyKeane as director of business development.Cytogen Corp., of Princeton, N.J., has appointed Richard Murawskivice president, operations.Miles Biotechnology has named Michael Johnson director of strategicplanning, and James Meade director of licensing.

(c) 1997 American Health Consultants. All rights reserved.